The previous study of PRR11 was conducted and interpreted in the setting of lung cancer and showed that PRR11-knockdown dysregulated the expression of multiple important gene in critical pathways such as cell cycle, tumorigenesis and metastasis (e.g. CCNA1, RRM1, MAP4K4 and EPB41L3)[9]. This evidence concerns the gene PRR11 and lung carcinoma.